4.6 Article

LIF/STAT3/SOCS3 Signaling Pathway in Murine Bone Marrow Stromal Cells Suppresses Osteoblast Differentiation

Journal

JOURNAL OF CELLULAR BIOCHEMISTRY
Volume 115, Issue 7, Pages 1262-1268

Publisher

WILEY
DOI: 10.1002/jcb.24777

Keywords

OSTEOBLASTS; BONE MARROW STROMAL CELLS; CELL DIFFERENTIATION; CYTOKINE; SIGNAL TRANSDUCTION

Funding

  1. Japan Society for the Promotion of Science [24689070, 25670809]
  2. Grants-in-Aid for Scientific Research [25670809, 24689070] Funding Source: KAKEN

Ask authors/readers for more resources

Leukemia inhibitory factor (LIF) is a pleiotropic cytokine that belongs to the interleukin-6 family and is expressed by multiple tissue types. This study analyzed the effect of LIF on osteoblast differentiation using primary murine bone marrow stromal cells (BMSCs). Colony-forming unit-osteoblast formation by BMSCs was significantly suppressed by LIF treatment. To clarify the mechanism underlying the LIF suppressive effect on osteoblast differentiation, we analyzed the downstream signaling pathway of LIF. LIF/signal transducer and activator of transcription 3 (STAT3) signaling induces the expression of suppressor of cytokine signaling 3 (SOCS3). SOCS3 knockdown experiments have previously demonstrated that short-hairpin SOCS3-BMSCs reversed the LIF suppressive effect. Our results demonstrated that LIF suppresses osteoblast differentiation through the LIF/STAT3/SOCS3 signaling pathway. J. Cell. Biochem. 115: 1262-1268, 2014. (c) 2014 Wiley Periodicals, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available